Yeow T. Goh

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications

Autologous stem cell transplantation for secondary central nervous system lymphoma: a multicentre retrospective analysis.

Autologous stem cell transplantation for secondary central nervous system lymphoma: a multicentre retrospective analysis.

Journal: BMC cancer
Published: May 18, 2026

The APLC expert consensus recommendations on the management of chronic lymphocytic leukaemia in Asia.

The APLC expert consensus recommendations on the management of chronic lymphocytic leukaemia in Asia.

Journal: Annals of the Academy of Medicine, Singapore
Published: April 01, 2026

Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.

Development and Validation of the Idiopathic Multicentric Castleman Disease Symptom Burden Scale (ISBUS): Protocol for an International Multistage Mixed Methods Study.

Journal: JMIR research protocols
Published: March 24, 2026

Overcoming Donor-Specific Anti-Human Leukocyte Antigen Antibodies With Desensitization in Adult Ex-Vivo T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation: A Real-World Analysis.

Overcoming Donor-Specific Anti-Human Leukocyte Antigen Antibodies With Desensitization in Adult Ex-Vivo T-Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation: A Real-World Analysis.

Journal: Transplantation and cellular therapy
Published: January 28, 2026

Second-line bosutinib for chronic phase chronic myeloid leukemia after imatinib: final, 10-year results of a phase I/II study.

Second-line bosutinib for chronic phase chronic myeloid leukemia after imatinib: final, 10-year results of a phase I/II study.

Journal: Haematologica
Published: November 13, 2025

Singapore Myeloma Study Group consensus guidelines for the management of patients with newly diagnosed multiple myeloma.

Singapore Myeloma Study Group consensus guidelines for the management of patients with newly diagnosed multiple myeloma.

Journal: Annals of the Academy of Medicine, Singapore
Published: October 07, 2025

Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results.

Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results.

Journal: Leukemia
Published: February 21, 2025

Deceased donor kidney transplantation in candidates with pre-transplant hematological malignancies: a literature review and recipient allocation proposal in Singapore.

Deceased donor kidney transplantation in candidates with pre-transplant hematological malignancies: a literature review and recipient allocation proposal in Singapore.

Journal: Journal of nephrology
Published: February 15, 2025

Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results.

Asciminib in combination with imatinib, nilotinib, or dasatinib in patients with chronic myeloid leukemia in chronic or accelerated phase: phase 1 study final results.

Journal: Leukemia
Published: February 14, 2025

Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia.

Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia.

Journal: International journal of hematology
Published: February 04, 2025

Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years.

Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years.

Journal: EJHaem
Published: February 03, 2025

Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience.

Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience.

Journal: Annals of the Academy of Medicine, Singapore
Published: January 31, 2025
Showing 1-12 of 75

Last Updated: 09/26/2026